That law, and others passed since, forced companies to rigorously test their products, running them through a gantlet of clinical trials whose results are then vetted by the F. D. A. before any sales to consumers. Ninety percent of drugs that enter clinical development fail these trials. (The F. D. A. also regulates medical devices, but they undergo a separate approval process.) As a result, newly discovered drugs can take years to reach the market, a period that Mr. Trump said last week was too lengthy. 